Related Experiment Video
Updated: Mar 24, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
The species, distribution, resistance of donor-derived pathogens and their impact on solid organ transplant
Yan-Man Zhou1, Xian-Quan Cui2, Peng Zhao2
1Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Background:
Donor-derived infections (DDIs) have become a significant cause of infection in organ transplant recipients. Elaborating on the species, distribution, and resistance of donor-derived pathogens (DDPs) holds important implications.
Methods:
A retrospective cohort study included 302 deceased donors and their corresponding 464 kidney transplant recipients and 175 liver transplant recipients. We detected DDPs in preservation fluid (PF) using both conventional culture and mNGS, and subsequently analyzed the incidence of DDIs after transplantation.
Results:
89.4% (270/302) of donors had positive cultures. Predominant multidrug-resistant organism included HLAR-Enterococcus, CRAB, CRKP, CRPA, MRS and ESBL-Escherichia coli. Compared with conventional culture, mNGS exhibited superior sensitivity for detecting bacteria and fungus in PF, with shorter turnaround time (p < 0.001). The incidences of DDIs in kidney and liver transplant recipients were 16.6% (77/464) and 19.4% (34/175) respectively. The recipients with DDIs were associated with elevated serum creatinine or total bilirubin levels, increased infection events, higher risks of graft loss, elevated mortality, and longer length of hospital stay (p < 0.05).
Conclusions:
Multidrug-resistant organism are prevalent in deceased donors, with PF contamination primarily originating from donors. Integration of mNGS into donor screening protocols enables timely antimicrobial intervention, potentially improving transplant outcomes.
Insights
Donor-derived infections are common in transplant recipients. Metagenomic next-generation sequencing (mNGS) of donor preservation fluid can detect pathogens, improving transplant outcomes.
Area of Science:
- Transplant Infectious Diseases
- Microbiology
- Genomics
Background:
- Donor-derived infections (DDIs) are a significant threat to organ transplant recipients.
- Understanding donor-derived pathogens (DDPs) is crucial for preventing DDIs.
Purpose of the Study:
- To investigate the prevalence and characteristics of DDPs in deceased donors.
- To compare the efficacy of conventional culture and mNGS for DDP detection.
- To determine the incidence and impact of DDIs on transplant recipients.
Main Methods:
- Retrospective cohort study of 302 deceased donors and 639 transplant recipients (464 kidney, 175 liver).
- Detection of DDPs in preservation fluid (PF) using conventional culture and mNGS.
- Analysis of DDI incidence and patient outcomes.
Main Results:
- 89.4% of donors had positive cultures, with prevalent multidrug-resistant organisms (MDROs).
- mNGS showed superior sensitivity and faster turnaround time than conventional culture for pathogen detection in PF.
- DDIs occurred in 16.6% of kidney and 19.4% of liver recipients, associated with adverse outcomes.
Conclusions:
- MDROs are common in deceased donors, with PF contamination frequently originating from the donor.
- Integrating mNGS into donor screening can facilitate timely antimicrobial interventions.
- Improved DDP detection via mNGS may enhance transplant outcomes.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Cell-mediated Immune Responses
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant II: Surgical Procedure
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

